EP1320367A4 - PROCESS FOR THE PRODUCTION OF DINAPSOLIN - Google Patents

PROCESS FOR THE PRODUCTION OF DINAPSOLIN

Info

Publication number
EP1320367A4
EP1320367A4 EP01967963A EP01967963A EP1320367A4 EP 1320367 A4 EP1320367 A4 EP 1320367A4 EP 01967963 A EP01967963 A EP 01967963A EP 01967963 A EP01967963 A EP 01967963A EP 1320367 A4 EP1320367 A4 EP 1320367A4
Authority
EP
European Patent Office
Prior art keywords
dinapsoline
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP01967963A
Other languages
German (de)
English (en)
French (fr)
Other versions
EP1320367A1 (en
Inventor
Sing-Yuen Sit
Swanee E Jacutin-Porte
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Purdue Research Foundation
Original Assignee
Purdue Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Purdue Research Foundation filed Critical Purdue Research Foundation
Publication of EP1320367A1 publication Critical patent/EP1320367A1/en
Publication of EP1320367A4 publication Critical patent/EP1320367A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/06—Peri-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04—Ortho- or peri-condensed ring systems
    • C07D221/18—Ring systems of four or more rings
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
EP01967963A 2000-08-11 2001-08-10 PROCESS FOR THE PRODUCTION OF DINAPSOLIN Withdrawn EP1320367A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US22496800P 2000-08-11 2000-08-11
US224968P 2000-08-11
PCT/US2001/025265 WO2002013827A1 (en) 2000-08-11 2001-08-10 Process for the preparation of dinapsoline

Publications (2)

Publication Number Publication Date
EP1320367A1 EP1320367A1 (en) 2003-06-25
EP1320367A4 true EP1320367A4 (en) 2007-01-17

Family

ID=22842980

Family Applications (1)

Application Number Title Priority Date Filing Date
EP01967963A Withdrawn EP1320367A4 (en) 2000-08-11 2001-08-10 PROCESS FOR THE PRODUCTION OF DINAPSOLIN

Country Status (12)

Country Link
US (1) US6645975B1 (xx)
EP (1) EP1320367A4 (xx)
JP (1) JP2004506014A (xx)
KR (1) KR20030027020A (xx)
CN (1) CN1473045A (xx)
AU (2) AU2001288242B2 (xx)
BR (1) BR0113170A (xx)
CA (1) CA2417807A1 (xx)
MX (1) MXPA03001272A (xx)
NO (1) NO20030515L (xx)
NZ (1) NZ524212A (xx)
WO (1) WO2002013827A1 (xx)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE365040T1 (de) * 2001-08-10 2007-07-15 Purdue Research Foundation Chirales dinapsolin
FR3017868A1 (fr) * 2014-02-21 2015-08-28 Servier Lab Derives d'isoquinoleine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
SG11202004461YA (en) 2017-11-24 2020-06-29 H Lundbeck As New catecholamine prodrugs for use in the treatment of parkinson's disease
US11168056B2 (en) 2019-05-20 2021-11-09 H. Lundbeck A/S Process for the manufacturing of (6aR,10aR)-7-propyl-6,6a,7,8,9,10,10a,11-octahydro-[1,3]dioxolo[4′,5′:5,6]benzo[1,2-G]quinoline and (4aR,10aR)-1-propyl-1,2,3,4,4a,5,10,10a-octahydro-benzo[G]quinoline-6,7-diol
US11111263B2 (en) 2019-05-20 2021-09-07 H. Lundbeck A/S Process for the manufacture of (2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(((4aR,10aR)-7-hydroxy-1-propyl-1,2,3,4,4a,5,10,10a-octahydrobenzo[g]quinolin-6-yl)oxy)tetrahydro-2H-pyran-2-carboxylic acid
US11104697B2 (en) 2019-05-20 2021-08-31 H. Lundbeck A/S Process for the manufacture of (2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(((4AR,10AR)-7-hydroxy-1- propyl-1,2,3,4,4A,5,10,10A-octahydrobenzo[g]quinolin-6-yl)oxy)tetrahydro-2H-pyran-2-carboxylic acid
US11130775B2 (en) 2019-05-20 2021-09-28 H. Lundbeck A/S Solid forms of (2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(((4aR,10aR)-7-hydroxy-1-propyl-1,2,3,4,4A,5,10,10A-octahydrobenzo[g]quinolin-6-yl)oxy)tetrahydro-2H-pyran-2-carboxylic acid

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2529580A1 (de) * 1974-08-07 1976-02-19 Aspro Nicholas Ltd Isochinolinderivate, verfahren zu ihrer herstellung und pharmazeutische zubereitungen, worin sie enthalten sind
CA1033358A (en) * 1974-09-03 1978-06-20 Ayerst, Mckenna And Harrison Limited Benzo(4,5)(1,2,3-ij)isoquinolines and process therefor
WO1997006799A1 (en) * 1995-08-18 1997-02-27 Purdue Research Foundation Novel fused isoquinolines as dopamine receptor ligands
WO1997030977A1 (en) * 1996-02-23 1997-08-28 Pharm-Eco Laboratories, Incorporated Selective d1 dopamine receptor agonists and partial agonists/antagonists

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2529580A1 (de) * 1974-08-07 1976-02-19 Aspro Nicholas Ltd Isochinolinderivate, verfahren zu ihrer herstellung und pharmazeutische zubereitungen, worin sie enthalten sind
CA1033358A (en) * 1974-09-03 1978-06-20 Ayerst, Mckenna And Harrison Limited Benzo(4,5)(1,2,3-ij)isoquinolines and process therefor
WO1997006799A1 (en) * 1995-08-18 1997-02-27 Purdue Research Foundation Novel fused isoquinolines as dopamine receptor ligands
WO1997030977A1 (en) * 1996-02-23 1997-08-28 Pharm-Eco Laboratories, Incorporated Selective d1 dopamine receptor agonists and partial agonists/antagonists

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
GHOSH, DEBASIS ET AL: "8,9-Dihydroxy-2,3,7,11b-tetrahydro-1H-naph[1,2,3-de]isoquinoline: A Poten Full Dopamine D1 Agonist Containing a Rigid.beta.-Phenyldopamine Pharmacophore", JOURNAL OF MEDICINAL CHEMISTRY, vol. 39, 1996, pages 549 - 555, XP001180670 *
QANDIL, AMJAD M. ET AL: "Alternative Formal Synthesis of the Potent D1 Dopamine Agonist Dihydroxy-2,3,7,11b-tetrahydro-1H- naphth[1,2,3-de]isoquinoline: Dinapsoline", JOURNAL OF ORGANIC CHEMISTRY, vol. 64, 1999, pages 1407 - 1409, XP009029313 *
SATTELKAU T ET AL: "AN EFFICIENT SYNTHESIS OF THE POTENT DOPAMINE D1 AGONIST DINAPSOLINE BY CONSTRUCTION AND SELECTIVE REDUCTION OF 2'-AZADIMETHOXYBENZANTHRONE", SYNTHESIS, GEORG THIEME VERLAG. STUTTGART, DE, no. 2, 2001, pages 262 - 266, XP002949177, ISSN: 0039-7881 *
See also references of WO0213827A1 *

Also Published As

Publication number Publication date
US6645975B1 (en) 2003-11-11
EP1320367A1 (en) 2003-06-25
JP2004506014A (ja) 2004-02-26
CA2417807A1 (en) 2002-02-21
NZ524212A (en) 2004-07-30
CN1473045A (zh) 2004-02-04
WO2002013827A1 (en) 2002-02-21
NO20030515L (no) 2003-03-31
BR0113170A (pt) 2004-01-06
AU8824201A (en) 2002-02-25
KR20030027020A (ko) 2003-04-03
NO20030515D0 (no) 2003-02-03
MXPA03001272A (es) 2004-04-02
AU2001288242B2 (en) 2005-11-17

Similar Documents

Publication Publication Date Title
HK1052183A1 (zh) 製造tetrahydrobenzothiepines的方法
HU0103291D0 (en) Process for the preparation of citalopram
IL187126A0 (en) Process for the preparation of 4 - haloalkylnicotinonitriles
IL143106A (en) Process for the preparation of diphenylmethylthioacetamide
AU6259701A (en) Process for the preparation of pyrazolopyrimidinones
AU8824201A (en) Process for the preparation of dinapsoline
IL190807A0 (en) Process for the preparation of 2-aminoethylpyridines
IL150897A0 (en) Process for the preparation of acetyl-amidiniophenylalanyl cyclohexylglycyl-pyridinioalaninamides
HUP0303025A3 (en) Process for the preparation of arylethanoldiamines
EG22846A (en) Process for the preparation of urea
HUP0202865A3 (en) Process for the preparation of 2-cyanopyridines
IL138691A (en) Process for the preparation of 3-acyl-indoles
SI1127876T1 (en) Process for the preparation of isoindoline
IL137364A (en) Process for the preparation of 6,6-dimethylhept-1-en-4-yn-3-ol
PL368905A1 (en) Process for the preparation of beta-ionylideneacetaldehyde
EG22758A (en) Process for the preparation of urea
GB0012249D0 (en) Process for the preparation of 11-oxaprostaglandins
AU2166302A (en) Process for the preparation of thiophenols
AU6259201A (en) Novel process for the preparation of pyrazolopyrimidinones
HU0003616D0 (en) Process for the preparation of pyridyl-ketone
GB0028881D0 (en) Process for the preparation of endo-5-norbornene-2-ol
GB0012996D0 (en) Process for the preparation of endo-5-norbornene-2-ol
AU2002231651A1 (en) Process for the preparation of morpholinones
GB0015462D0 (en) Novel process for the preparation of pyrazolopyrimidinones
IL155995A0 (en) New process for the preparation of diaryl-4-amino-piperidinyl compounds

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20030221

AK Designated contracting states

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

AX Request for extension of the european patent

Extension state: AL LT LV MK RO SI

RIC1 Information provided on ipc code assigned before grant

Ipc: 7C 07D 491/06 B

Ipc: 7C 07D 221/18 B

Ipc: 7A 61P 25/14 B

Ipc: 7A 61K 31/4741 B

Ipc: 7A 61K 31/473 A

A4 Supplementary search report drawn up and despatched

Effective date: 20061218

18W Application withdrawn

Effective date: 20070828

D18W Application withdrawn (deleted)
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20080303

R18D Application deemed to be withdrawn (corrected)

Effective date: 20080301

REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1056329

Country of ref document: HK